CXCR4-targeted PET/CT with Al18F-NOTA-Pentixather shows superior sensitivity to 18F-FDG in thyroid follicular lymphoma.

F-FDG in low-grade lymphomas and suggests that CXCR4-targeted PET/CT may offer a more accurate reflection of disease burden, with potential implications for staging and therapeutic management.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-09-06
DOI
https://doi.org/10.1967/s002449913013
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CXCR4-targeted PET/CT with Al18F-NOTA-Pentixather shows superior sensitivity to 18F-FDG in thyroid follicular lymphoma.

Yanqing Diao, Caiqun Zhou
PubMed
Lymphoma Diagnosis and Treatment
article

CXCR4-targeted PET/CT with Al18F-NOTA-Pentixather shows superior sensitivity to 18F-FDG in thyroid follicular lymphoma.

Yanqing Diao, Caiqun Zhou
article en

Abstract

F-FDG in low-grade lymphomas and suggests that CXCR4-targeted PET/CT may offer a more accurate reflection of disease burden, with potential implications for staging and therapeutic management.

PubMedVol. 29(2)
Chengdu Fifth People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 10%
Lymphoma Diagnosis and Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.